Molecular mechanism for strengthening E-cadherin adhesion using a monoclonal antibody
- PMID: 35921442
- PMCID: PMC9371698
- DOI: 10.1073/pnas.2204473119
Molecular mechanism for strengthening E-cadherin adhesion using a monoclonal antibody
Abstract
E-cadherin (Ecad) is an essential cell-cell adhesion protein with tumor suppression properties. The adhesive state of Ecad can be modified by the monoclonal antibody 19A11, which has potential applications in reducing cancer metastasis. Using X-ray crystallography, we determine the structure of 19A11 Fab bound to Ecad and show that the antibody binds to the first extracellular domain of Ecad near its primary adhesive motif: the strand-swap dimer interface. Molecular dynamics simulations and single-molecule atomic force microscopy demonstrate that 19A11 interacts with Ecad in two distinct modes: one that strengthens the strand-swap dimer and one that does not alter adhesion. We show that adhesion is strengthened by the formation of a salt bridge between 19A11 and Ecad, which in turn stabilizes the swapped β-strand and its complementary binding pocket. Our results identify mechanistic principles for engineering antibodies to enhance Ecad adhesion.
Keywords: 19A11; E-cadherin; adhesion; antibody; strand–swap dimer.
Conflict of interest statement
The authors declare no competing interest.
Figures
References
-
- Alsaleem M., et al. , The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: High throughput analysis of large cohorts. Mod. Pathol. 32, 967–976 (2019). - PubMed
